Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients

Silvana Canevari, Giuseppe Fossati, Silvia Miotti, Giuseppe Della Porta, Cesare Grandi, Giorgio Pizzocaro

Research output: Contribution to journalArticle

Abstract

A positive delayed cutaneous hypersensitivity reaction (DCHR) was observed to only one of five KCl soluble extracts from as many different tumoral kidneys in nine of 11 patients with kidney cancer. None of the autologous normal renal tissue extracts gave a positive reaction. SDS-PAGE analysis showed a predominant component with a molecular weight corresponding to that of serum albumin in all the four negative cancer extracts. Lipoproteins and serum albumin were removed by ultracentrifugal flotation on KBr and by affinity chromatography on antiserum albumin (α-HSA), respectively, from one of the negative crude extracts. KCl extract, F2 fraction of KBr, and unbound material from the α-HSA column were injected simultaneously into nine patients with renal cancer. Positive DCHRs were seen to the three extracts in no patients, in three, and in eight, respectively. The α-HSA unbound fraction was positive in three of 13 patients with tumor at a site other than the kidney. The same extraction procedure was applied to normal autologous kidney tissue, and positive reactivity was observed in one of eight and three of nine patients with kidney cancer to the F2 and α-HSA unbound fractions, respectively. An aliquot of KCl tumor extract was passed through the α-HSA column without the preliminary flotation on KBr, and the unbound fraction was positive in eight of nine patients with kidney cancer and in eight of twelve patients with other types of tumor. Three different melanomas were extracted in the same way and an increased percentage of DCHRs was found after removal of lipoproteins and HSA in melanoma patients. This reactivity, however, was not histologically related since patients with tumors other than melanoma reacted as well as melanoma patients. These data indicate that the removal of lipoproteins and HSA from crude tumor extracts may unmask or increase an existing antigenicity. The tumor-type-related experiments, however, suggest that these biochemical procedures are useful for kidney tumors but not for melanomas.

Original languageEnglish
Pages (from-to)81-85
Number of pages5
JournalCancer Immunology, Immunotherapy
Volume11
Issue number1
DOIs
Publication statusPublished - May 1981

Fingerprint

Delayed Hypersensitivity
Skin
Kidney Neoplasms
Melanoma
Neoplasms
Kidney
Lipoproteins
Complex Mixtures
Serum Albumin
Tissue Extracts
Affinity Chromatography
Immune Sera
Polyacrylamide Gel Electrophoresis
Albumins
Molecular Weight

ASJC Scopus subject areas

  • Oncology
  • Immunology
  • Cancer Research

Cite this

Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients. / Canevari, Silvana; Fossati, Giuseppe; Miotti, Silvia; Della Porta, Giuseppe; Grandi, Cesare; Pizzocaro, Giorgio.

In: Cancer Immunology, Immunotherapy, Vol. 11, No. 1, 05.1981, p. 81-85.

Research output: Contribution to journalArticle

Canevari, S, Fossati, G, Miotti, S, Della Porta, G, Grandi, C & Pizzocaro, G 1981, 'Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients', Cancer Immunology, Immunotherapy, vol. 11, no. 1, pp. 81-85. https://doi.org/10.1007/BF00205779
Canevari, Silvana ; Fossati, Giuseppe ; Miotti, Silvia ; Della Porta, Giuseppe ; Grandi, Cesare ; Pizzocaro, Giorgio. / Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients. In: Cancer Immunology, Immunotherapy. 1981 ; Vol. 11, No. 1. pp. 81-85.
@article{a2a78315f7d142d6b85129a92100187a,
title = "Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients",
abstract = "A positive delayed cutaneous hypersensitivity reaction (DCHR) was observed to only one of five KCl soluble extracts from as many different tumoral kidneys in nine of 11 patients with kidney cancer. None of the autologous normal renal tissue extracts gave a positive reaction. SDS-PAGE analysis showed a predominant component with a molecular weight corresponding to that of serum albumin in all the four negative cancer extracts. Lipoproteins and serum albumin were removed by ultracentrifugal flotation on KBr and by affinity chromatography on antiserum albumin (α-HSA), respectively, from one of the negative crude extracts. KCl extract, F2 fraction of KBr, and unbound material from the α-HSA column were injected simultaneously into nine patients with renal cancer. Positive DCHRs were seen to the three extracts in no patients, in three, and in eight, respectively. The α-HSA unbound fraction was positive in three of 13 patients with tumor at a site other than the kidney. The same extraction procedure was applied to normal autologous kidney tissue, and positive reactivity was observed in one of eight and three of nine patients with kidney cancer to the F2 and α-HSA unbound fractions, respectively. An aliquot of KCl tumor extract was passed through the α-HSA column without the preliminary flotation on KBr, and the unbound fraction was positive in eight of nine patients with kidney cancer and in eight of twelve patients with other types of tumor. Three different melanomas were extracted in the same way and an increased percentage of DCHRs was found after removal of lipoproteins and HSA in melanoma patients. This reactivity, however, was not histologically related since patients with tumors other than melanoma reacted as well as melanoma patients. These data indicate that the removal of lipoproteins and HSA from crude tumor extracts may unmask or increase an existing antigenicity. The tumor-type-related experiments, however, suggest that these biochemical procedures are useful for kidney tumors but not for melanomas.",
author = "Silvana Canevari and Giuseppe Fossati and Silvia Miotti and {Della Porta}, Giuseppe and Cesare Grandi and Giorgio Pizzocaro",
year = "1981",
month = "5",
doi = "10.1007/BF00205779",
language = "English",
volume = "11",
pages = "81--85",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Delayed cutaneous hypersensitivity reaction to crude and semi-purified tumor extracts in cancer patients

AU - Canevari, Silvana

AU - Fossati, Giuseppe

AU - Miotti, Silvia

AU - Della Porta, Giuseppe

AU - Grandi, Cesare

AU - Pizzocaro, Giorgio

PY - 1981/5

Y1 - 1981/5

N2 - A positive delayed cutaneous hypersensitivity reaction (DCHR) was observed to only one of five KCl soluble extracts from as many different tumoral kidneys in nine of 11 patients with kidney cancer. None of the autologous normal renal tissue extracts gave a positive reaction. SDS-PAGE analysis showed a predominant component with a molecular weight corresponding to that of serum albumin in all the four negative cancer extracts. Lipoproteins and serum albumin were removed by ultracentrifugal flotation on KBr and by affinity chromatography on antiserum albumin (α-HSA), respectively, from one of the negative crude extracts. KCl extract, F2 fraction of KBr, and unbound material from the α-HSA column were injected simultaneously into nine patients with renal cancer. Positive DCHRs were seen to the three extracts in no patients, in three, and in eight, respectively. The α-HSA unbound fraction was positive in three of 13 patients with tumor at a site other than the kidney. The same extraction procedure was applied to normal autologous kidney tissue, and positive reactivity was observed in one of eight and three of nine patients with kidney cancer to the F2 and α-HSA unbound fractions, respectively. An aliquot of KCl tumor extract was passed through the α-HSA column without the preliminary flotation on KBr, and the unbound fraction was positive in eight of nine patients with kidney cancer and in eight of twelve patients with other types of tumor. Three different melanomas were extracted in the same way and an increased percentage of DCHRs was found after removal of lipoproteins and HSA in melanoma patients. This reactivity, however, was not histologically related since patients with tumors other than melanoma reacted as well as melanoma patients. These data indicate that the removal of lipoproteins and HSA from crude tumor extracts may unmask or increase an existing antigenicity. The tumor-type-related experiments, however, suggest that these biochemical procedures are useful for kidney tumors but not for melanomas.

AB - A positive delayed cutaneous hypersensitivity reaction (DCHR) was observed to only one of five KCl soluble extracts from as many different tumoral kidneys in nine of 11 patients with kidney cancer. None of the autologous normal renal tissue extracts gave a positive reaction. SDS-PAGE analysis showed a predominant component with a molecular weight corresponding to that of serum albumin in all the four negative cancer extracts. Lipoproteins and serum albumin were removed by ultracentrifugal flotation on KBr and by affinity chromatography on antiserum albumin (α-HSA), respectively, from one of the negative crude extracts. KCl extract, F2 fraction of KBr, and unbound material from the α-HSA column were injected simultaneously into nine patients with renal cancer. Positive DCHRs were seen to the three extracts in no patients, in three, and in eight, respectively. The α-HSA unbound fraction was positive in three of 13 patients with tumor at a site other than the kidney. The same extraction procedure was applied to normal autologous kidney tissue, and positive reactivity was observed in one of eight and three of nine patients with kidney cancer to the F2 and α-HSA unbound fractions, respectively. An aliquot of KCl tumor extract was passed through the α-HSA column without the preliminary flotation on KBr, and the unbound fraction was positive in eight of nine patients with kidney cancer and in eight of twelve patients with other types of tumor. Three different melanomas were extracted in the same way and an increased percentage of DCHRs was found after removal of lipoproteins and HSA in melanoma patients. This reactivity, however, was not histologically related since patients with tumors other than melanoma reacted as well as melanoma patients. These data indicate that the removal of lipoproteins and HSA from crude tumor extracts may unmask or increase an existing antigenicity. The tumor-type-related experiments, however, suggest that these biochemical procedures are useful for kidney tumors but not for melanomas.

UR - http://www.scopus.com/inward/record.url?scp=0019462643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019462643&partnerID=8YFLogxK

U2 - 10.1007/BF00205779

DO - 10.1007/BF00205779

M3 - Article

AN - SCOPUS:0019462643

VL - 11

SP - 81

EP - 85

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 1

ER -